Clinical Trials Logo

Metachromatic Leukodystrophy clinical trials

View clinical trials related to Metachromatic Leukodystrophy.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT03639844 No longer available - Clinical trials for Inborn Errors of Metabolism

BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Start date: n/a
Phase:
Study type: Expanded Access

Providing access of BPX-501 gene modified T cells and rimiducid to pediatric patients who do not meet the eligibility criteria of the BP-U-004 study.

NCT ID: NCT02084121 No longer available - Clinical trials for Metachromatic Leukodystrophy

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)

Start date: n/a
Phase:
Study type: Expanded Access

A subject was treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rather than the Max Sep (Baxter) device.

NCT ID: NCT02021266 No longer available - Clinical trials for Metachromatic Leukodystrophy

Single Patient Expanded Access Protocol: Metabolic Boost

Boost
Start date: n/a
Phase:
Study type: Expanded Access

This is a single patient expanded access protocol to investigate the effects of a second dose of facilitating cell-enhanced hematopoietic stem cell product.